Linked Life Data

17020973

Source:http://linkedlifedata.com/resource/pubmed/id/17020973

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
19
pubmed:dateCreated
2006-10-5
pubmed:abstractText
Biomarkers can facilitate diagnosis, monitor treatment response, and assess prognosis in some patients with cancer. YKL-40 and matrix metalloproteinase-9 (MMP-9) are two proteins highly differentially expressed by malignant gliomas. We obtained prospective longitudinal serum samples from patients with gliomas to determine whether YKL-40 or MMP-9 could be used as serum markers.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1078-0432
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
12
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
5698-704
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:17020973-Adipokines, pubmed-meshheading:17020973-Adult, pubmed-meshheading:17020973-Aged, pubmed-meshheading:17020973-Aged, 80 and over, pubmed-meshheading:17020973-Autoantigens, pubmed-meshheading:17020973-Case-Control Studies, pubmed-meshheading:17020973-Female, pubmed-meshheading:17020973-Glioblastoma, pubmed-meshheading:17020973-Glycoproteins, pubmed-meshheading:17020973-Growth Substances, pubmed-meshheading:17020973-Humans, pubmed-meshheading:17020973-Lectins, pubmed-meshheading:17020973-Longitudinal Studies, pubmed-meshheading:17020973-Male, pubmed-meshheading:17020973-Matrix Metalloproteinase 9, pubmed-meshheading:17020973-Middle Aged, pubmed-meshheading:17020973-Oligodendroglioma, pubmed-meshheading:17020973-Prognosis, pubmed-meshheading:17020973-Prospective Studies, pubmed-meshheading:17020973-Survival Rate, pubmed-meshheading:17020973-Tumor Markers, Biological
pubmed:year
2006
pubmed:articleTitle
YKL-40 and matrix metalloproteinase-9 as potential serum biomarkers for patients with high-grade gliomas.
pubmed:affiliation
Clinical Laboratories, Neurosurgical Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA. hormigoa@mskcc.org
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't